Dashboard
Manage Tickers

GPCR


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
FDA Launches Green List To Protect America...
09/05/2025 15:40:06

https://www.fda.gov/news-events/press-announcements/fda-launches-green-list-protect-americans-illegal-imported-glp-1-drug-ingre...

hc-wainwright--co-maintains-buy-on-structure-therapeutics-lowers-price-target-to-60
HC Wainwright & Co. Maintains Buy on Struc...
08/07/2025 15:45:32

HC Wainwright & Co. analyst Ananda Ghosh maintains Structure Therapeutics (NASDAQ:GPCR) with a Buy and lowers the price ...

guggenheim-maintains-buy-on-structure-therapeutics-lowers-price-target-to-90
Guggenheim Maintains Buy on Structure Ther...
08/07/2025 14:12:49

Guggenheim analyst Seamus Fernandez maintains Structure Therapeutics (NASDAQ:GPCR) with a Buy and lowers the price target fr...

eli-lillys-rare-weight-loss-data-miss-could-benefit-competitors
Eli Lilly's Rare Weight Loss Data Miss Cou...
08/07/2025 13:55:46

Eli Lilly's obesity drug data misses targets, boosting shares of Novo Nordisk, Viking, Structure, and Terns amid promising ...

jmp-securities-maintains-market-outperform-on-structure-therapeutics-lowers-price-target-to-87
JMP Securities Maintains Market Outperform...
08/07/2025 13:27:23

JMP Securities analyst Jonathan Wolleben maintains Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform and lowers ...

structure-therapeutics-inc-files-for-mixed-shelf-sales-agreement-prospectus-covers-offering-of-up-to-250m-adss-representing-ordinary-shares
Structure Therapeutics Inc Files For Mixed...
08/06/2025 21:43:14

-SEC Filing

structure-therapeutics-q2-eps-036-misses-025-estimate
Structure Therapeutics Q2 EPS $(0.36) Miss...
08/06/2025 21:00:14

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate...

cantor-fitzgerald-reiterates-overweight-on-structure-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/23/2025 14:32:44

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $6...

jmp-securities-reiterates-market-outperform-on-structure-therapeutics-maintains-89-price-target
JMP Securities Reiterates Market Outperfor...
06/23/2025 13:13:53

JMP Securities analyst Jonathan Wolleben reiterates Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform and mainta...

reported-friday-structure-therapeutics-showcases-oral-glp-1-agonists-neuroprotective-effects-in-parkinsons-mouse-model-at-ada-scientific-sessions
Reported Friday, Structure Therapeutics Sh...
06/23/2025 09:02:27

hc-wainwright--co-maintains-buy-on-structure-therapeutics-lowers-price-target-to-75
HC Wainwright & Co. Maintains Buy on Struc...
05/12/2025 12:11:34

HC Wainwright & Co. analyst Andrew Fein maintains Structure Therapeutics (NASDAQ:GPCR) with a Buy and lowers the price t...

citigroup-initiates-coverage-on-structure-therapeutics-with-buy-rating-announces-price-target-of-60
Citigroup Initiates Coverage On Structure ...
05/02/2025 13:21:03

Citigroup analyst Samantha Semenkow initiates coverage on Structure Therapeutics (NASDAQ:GPCR) with a Buy rating and announc...

hc-wainwright--co-maintains-buy-on-structure-therapeutics-maintains-80-price-target
HC Wainwright & Co. Maintains Buy on Struc...
04/22/2025 10:17:04

HC Wainwright & Co. analyst Andrew Fein maintains Structure Therapeutics (NASDAQ:GPCR) with a Buy and maintains $80 pric...

uniqure-hertz-global-eli-lilly-and-other-big-stocks-moving-higher-on-thursday
uniQure, Hertz Global, Eli Lilly And Other...
04/17/2025 14:30:55

whats-going-on-with-viking-therapeutics-structure-therapeutics-stock-on-monday
What's Going On With Viking Therapeutics, ...
04/14/2025 14:49:19

Pfizer ends danuglipron development after liver safety issue, boosting shares of Viking, Eli Lilly, and Novo Nordisk amid obesi...

citizens-capital-markets-maintains-market-outperform-on-structure-therapeutics-lowers-price-target-to-87
Citizens Capital Markets Maintains Market ...
02/28/2025 15:48:16

Citizens Capital Markets analyst Jonathan Wolleben maintains Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform a...

william-blair-initiates-coverage-on-structure-therapeutics-with-outperform-rating
William Blair Initiates Coverage On Struct...
02/28/2025 12:06:20

William Blair analyst Andy Hsieh initiates coverage on Structure Therapeutics (NASDAQ:GPCR) with a Outperform rating.

structure-therapeutics-fy-2024-gaap-eps-078-beats-080-estimate
Structure Therapeutics FY 2024 GAAP EPS $(...
02/27/2025 22:13:54

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate o...

stifel-initiates-coverage-on-structure-therapeutics-with-buy-rating-announces-price-target-of-50
Stifel Initiates Coverage On Structure The...
01/08/2025 10:09:12

Stifel analyst Annabel Samimy initiates coverage on Structure Therapeutics (NASDAQ:GPCR) with a Buy rating and announces Pri...

viking-therapeutics-structure-therapeutics-positioned-as-key-pharma-partners-for-weight-loss-products-analyst
Viking Therapeutics, Structure Therapeutic...
01/06/2025 19:53:01

JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION